NEW DELHI: The central drug regulator has issued a notice of proven cause to the Serum Institute of India (SII) for not informing it about the pharmaceutical giant AstraZeneca that is pausing clinical trials of the Oxford vaccine candidate for Covid-19 in other countries and also for not presenting an …
Read More »Serum Institute Receives Notice from DCGI Regarding Suspension of Oxford Covid-19 Vaccine Trial by AstraZeneca Abroad | India News
